WuXi AppTec Nantong Site Wins Prestigious 2025 Architizer A+Award

WuXi AppTec's Architectural Marvel Receives Global Recognition



WuXi AppTec, a global ecosystem that provides comprehensive R&D and manufacturing services to the pharmaceutical and life sciences sectors, proudly announces that its Nantong facility has been honored with the Popular Choice Winner title in the 'Factory & Warehouse' category at the renowned 2025 Architizer A+Awards. This accolade not only emphasizes WuXi AppTec's dedication to innovative, human-centered work environments but also showcases the company’s commitment to empowering its workforce while enhancing patient care through transformative therapies.

The Architizer A+Awards, recognized globally for celebrating pioneering architectural designs, received thousands of submissions from over 80 countries. WuXi AppTec’s Nantong site distinguished itself through its groundbreaking design concept, termed 'technological-humanistic symbiosis.' This visionary approach merges advanced technology with a focus on human well-being, setting a benchmark for modern workplace design within the pharmaceutical industry.

Located in Jiangsu province, China, the Nantong site serves as a fundamental part of WuXi AppTec’s Contract Research, Development, and Manufacturing Organization (CRDMO) platform. It delivers a broad array of chemistry, biology, and testing solutions for its international clientele. Designed by the esteemed architectural firm Highlite Images, the facility encompasses eight principal buildings organized into two clusters. This thoughtful arrangement promotes collaboration and innovation, all while blending seamlessly with the surrounding urban landscape and natural environment.

The striking Z-shaped laboratory provides a unique urban appeal, facilitating a smooth connection among scientific research, community engagement, and environmental consciousness. The configuration not only enhances operational efficiency but also prioritizes the well-being of employees, reflecting WuXi AppTec’s holistic approach towards workplace functionality.

WuXi AppTec’s Nantong site is also part of a larger global commitment to intertwining technology with sustainability and community involvement in its operations. The company’s facilities, such as the Couvet site in Switzerland which adheres to industry-leading energy efficiency standards, along with the Munich site in Germany that boasts a LEED Platinum certification for its sustainable construction practices, underscore this noble endeavour. This wider vision ensures that WuXi AppTec reinforces its position at the forefront of the pharmaceutical and healthcare industry.

The company’s pledge extends beyond architecture and sustainability as it strives to build a healthier future—one where 'every drug can be made and every disease can be treated.' With operations across Asia, Europe, and North America, WuXi AppTec caters to a global clientele, aiding them in accelerating healthcare advancements through its integrated and comprehensive services. In 2024, WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year, reflecting its commitment to social responsibility and ethical governance.

As WuXi AppTec continues to expand its influence and reach, the Nantong site stands as a hallmark of innovation, exemplifying the company’s mission to empower the pharmaceutical and life science industries while transforming patient outcomes worldwide. By fostering a culture of efficiency, sustainability, and teamwork, WuXi AppTec is paving the way for the future of healthcare solutions, ensuring that the advancements of today lead to the breakthroughs of tomorrow.

Topics General Business)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.